CME Group Inc. $CME Shares Bought by Solstein Capital LLC

Solstein Capital LLC grew its position in shares of CME Group Inc. (NASDAQ:CME) by 35.0% during the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 1,108 shares of the financial services provider’s stock after purchasing an additional 287 shares during the period. Solstein Capital LLC’s holdings in CME Group were worth $305,000 as of its most recent SEC filing.

Other large investors also recently added to or reduced their stakes in the company. Catalyst Capital Advisors LLC lifted its stake in CME Group by 256.9% during the first quarter. Catalyst Capital Advisors LLC now owns 3,662 shares of the financial services provider’s stock worth $971,000 after purchasing an additional 2,636 shares in the last quarter. OMNI 360 Wealth Inc. acquired a new stake in shares of CME Group in the first quarter valued at $367,000. Fulcrum Equity Management acquired a new stake in shares of CME Group in the first quarter valued at $258,000. AIA Group Ltd raised its stake in shares of CME Group by 17.8% in the first quarter. AIA Group Ltd now owns 16,645 shares of the financial services provider’s stock valued at $4,416,000 after acquiring an additional 2,510 shares in the last quarter. Finally, Insight Inv LLC acquired a new stake in shares of CME Group in the first quarter valued at $2,712,000. 87.75% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

CME has been the topic of several analyst reports. Citigroup upgraded CME Group from a “neutral” rating to a “buy” rating and increased their price objective for the company from $275.00 to $300.00 in a research note on Thursday, September 25th. Keefe, Bruyette & Woods increased their price objective on CME Group from $283.00 to $287.00 and gave the company a “market perform” rating in a research note on Monday, October 13th. The Goldman Sachs Group increased their price objective on CME Group from $262.00 to $263.00 and gave the company a “sell” rating in a research note on Thursday. Barclays reduced their price objective on CME Group from $298.00 to $280.00 and set an “equal weight” rating on the stock in a research note on Wednesday, October 8th. Finally, UBS Group reduced their price objective on CME Group from $285.00 to $280.00 and set a “neutral” rating on the stock in a research note on Thursday. Eight research analysts have rated the stock with a Buy rating, six have given a Hold rating and three have given a Sell rating to the company. According to MarketBeat, the company presently has an average rating of “Hold” and an average target price of $284.53.

Insider Transactions at CME Group

In other CME Group news, insider Timothy Francis Mccourt sold 379 shares of the firm’s stock in a transaction dated Tuesday, September 16th. The stock was sold at an average price of $259.83, for a total transaction of $98,475.57. Following the transaction, the insider owned 9,508 shares of the company’s stock, valued at approximately $2,470,463.64. This trade represents a 3.83% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, insider Sunil Cutinho sold 11,896 shares of the firm’s stock in a transaction dated Tuesday, August 26th. The stock was sold at an average price of $271.47, for a total value of $3,229,407.12. Following the transaction, the insider directly owned 17,440 shares in the company, valued at approximately $4,734,436.80. The trade was a 40.55% decrease in their position. The disclosure for this sale can be found here. In the last ninety days, insiders sold 13,043 shares of company stock worth $3,527,956. 0.30% of the stock is owned by company insiders.

CME Group Stock Performance

NASDAQ:CME opened at $269.54 on Monday. The firm has a market capitalization of $97.14 billion, a PE ratio of 26.12, a price-to-earnings-growth ratio of 6.65 and a beta of 0.41. The business’s fifty day moving average price is $266.47 and its 200 day moving average price is $271.90. The company has a debt-to-equity ratio of 0.12, a current ratio of 1.02 and a quick ratio of 1.02. CME Group Inc. has a 12 month low of $213.94 and a 12 month high of $290.79.

CME Group (NASDAQ:CME) last posted its earnings results on Wednesday, October 22nd. The financial services provider reported $2.68 EPS for the quarter, beating the consensus estimate of $2.63 by $0.05. The firm had revenue of $1.54 billion for the quarter, compared to analyst estimates of $1.56 billion. CME Group had a return on equity of 14.61% and a net margin of 58.84%.CME Group’s revenue for the quarter was down 3.0% compared to the same quarter last year. During the same quarter in the prior year, the company posted $2.68 earnings per share. On average, sell-side analysts anticipate that CME Group Inc. will post 10.49 earnings per share for the current fiscal year.

CME Group Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Thursday, September 25th. Shareholders of record on Tuesday, September 9th were issued a dividend of $1.25 per share. The ex-dividend date of this dividend was Tuesday, September 9th. This represents a $5.00 annualized dividend and a dividend yield of 1.9%. CME Group’s dividend payout ratio (DPR) is presently 48.45%.

CME Group Company Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.